Table 1

Clinical and genetic findings

Patient no.Absolute neutrophil count at diagnosis/at sampling after G-CSF therapyELA2*HAX1*Bacterial infections
1; SCN recessive 0.0/6.0 allo-BMT WT Q190X No periodontal disease, skin abscess, paronychia 
2; SCN recessive 0.1/5.7 WT Q190X Chronic gingivitis, skin abscess, otitis 
3; SCN sporadic 0.05/12.8 L92H WT Severe periodontitis, skin abscess, tonsillitis 
7; SCN sporadic 0.2/11.3 WT WT No periodontal disease, skin abscess 
15; SCN dominant 0.2/NA C26S NA Chronic gingivitis, septicemia, oitis  
Patient no.Absolute neutrophil count at diagnosis/at sampling after G-CSF therapyELA2*HAX1*Bacterial infections
1; SCN recessive 0.0/6.0 allo-BMT WT Q190X No periodontal disease, skin abscess, paronychia 
2; SCN recessive 0.1/5.7 WT Q190X Chronic gingivitis, skin abscess, otitis 
3; SCN sporadic 0.05/12.8 L92H WT Severe periodontitis, skin abscess, tonsillitis 
7; SCN sporadic 0.2/11.3 WT WT No periodontal disease, skin abscess 
15; SCN dominant 0.2/NA C26S NA Chronic gingivitis, septicemia, oitis  

Allo-BMT indicates allogeneic bone marrow transplantation; WT, wild type; and NA, not analyzed.

*

Amino acid numbers in ELA2 (Gene ID, 1991) correspond to the first residue after the signal peptide and the first residue in HAX1 (Gene ID/0456).

or Create an Account

Close Modal
Close Modal